Supply breakdown
Shares as of Jul 31, 2026| Category | Shares | % | Value | Status |
|---|---|---|---|---|
| Circulating | 1.48B | 100.0% | $32.40B | Estimated |
| Free float | - | - | - | Unavailable |
| Insider-held, unrestricted | - | - | - | Unavailable |
| Locked team funds | - | - | - | Unavailable |
| Other restricted (unlisted classes only) | - | - | - | Unavailable |
| Total outstanding | 1.48B | 100.0% | $32.40B | Verified |
| Ownership views (overlap the categories above, never added) | ||||
| Institutional holdings (13F) | 454.64M | 30.8% | $9.97B | Estimated |
| Insider-held, all (Forms 3, 4, 5) | - | - | - | Unavailable |
Institutional and insider holdings can include both tradable and locked shares, so they are shown for reference and never added to the total. Check: no class has more shares deducted than it has outstanding, and the review found no shares that may be counted twice: reconciles.
Valuation
- Traditional$32.40B
- Fully diluted$33.60B
- Circulating$32.40B
- Free float-
- Locked team value$0
- Other restricted value$0
Locked and restricted shares
Not reviewed yet.
Institutional holders
13F, quarter ended Jun 30, 2026| Holder | Shares | % of total |
|---|---|---|
| BAKER BROS. ADVISORS LP | 114.42M | 7.74% |
| PRIMECAP MANAGEMENT CO/CA/ | 65.10M | 4.40% |
| Capital International Investors | 54.73M | 3.70% |
| FMR LLC | 32.22M | 2.18% |
| Capital World Investors | 29.24M | 1.98% |
| CITADEL ADVISORS LLC | 18.53M | 1.25% |
| Temasek Holdings (Private) Ltd | 10.99M | 0.74% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 9.86M | 0.67% |
| BlackRock, Inc. | 9.03M | 0.61% |
| MILLENNIUM MANAGEMENT LLC | 7.06M | 0.48% |
Sum of long share positions in Form 13F reports for the quarter. 13F covers managers with over $100M in US equities; some positions are reported by more than one filer. Positions are reported in ADSs and converted at 13 ordinary shares per ADS.
Insiders
Forms 3, 4 and 5Form 4 aggregation pending
Share classes
| Class | Listing | Shares outstanding | As of |
|---|---|---|---|
| Ordinary shares (as ADS) | ONC on Nasdaq | 1,478,124,405 | Jul 31, 2026 |
Notes and sources
- BeOne Medicines Ltd. 10-Q for period ended 2026-06-30, Cover page (0001628280-26-052878)
- SEC public float (non-affiliates): $14.70B as of Jun 30, 2025, from the 10-K cover. It is a dollar value at a past date, not circulating supply.